| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |